"10.1371_journal.pone.0058816","plos one","2013-03-15T00:00:00Z","K Abigail Andrews; Marc Modat; Kate E Macdonald; Tom Yeatman; M Jorge Cardoso; Kelvin K Leung; Josephine Barnes; Victor L Villemagne; Christopher C Rowe; Nick C Fox; Sebastien Ourselin; Jonathan M Schott; the Australian Imaging Biomarkers; Lifestyle Flagship Study of Ageing","Dementia Research Centre (DRC), University College London, London, United Kingdom; Centre for Medical Image Computing (CMIC), University College London, London, United Kingdom; Austin Health, Department of Nuclear Medicine and Centre for PET, Heidelberg, Victoria, Australia","Performed expert segmentations: TY KEM. Contributed methods and software used for automatic segmentation/registration/atrophy quantification: MJC MM KKL. Contributed critically to data interpretation: JB NCF SO. Performed data acquisition: VLV CCR. Contributed critically to revision of manuscript: NCF SO VLV KKL MJC MM KEM JB TY CCR. Conceived and designed the experiments: KAA JMS JB SO NCF. Performed the experiments: KAA MM MJC KKL. Analyzed the data: KAA JMS. Contributed reagents/materials/analysis tools: VLV CCR. Wrote the paper: KAA JMS.","KA is funded by an EPSRC (www.epsrc.ac.uk) industrial CASE PhD studentship http://www.epsrc.ac.uk/skills/students/coll/icase/Pages/intro.aspx) co-sponsored by commercial partner IXICO Ltd (www.ixico.com). The DRC holds a patent for QA Box (automated quality assurance for scan acquisition parameters), which may accrue revenue in the future, and currently receives royalties from Midas image processing software licences. NF has provided consultancy to GE Healthcare, Janssen-Cilag, Janssen-Elan pharmaceuticals, AVID Radiopharmaceuticals Inc, Lilly Research Labs, Eisai Inc and Johnson & Johnson; CR holds grants from CSIRO, Bayer, Avid Radiopharmaceuticals, GE Healthcare and Astra Zeneca; VV has provided consultancy to Bayer Healthcare and holds a grant from NHMRC/ADDF; JS receives grant funding from AVID Radiopharmaceuticals Inc and receives royalties from Henry Stewart talks. There are no further patents, products in development or marketed products to declare. This does not alter the authorsâ€™ adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.","2013","03","K Abigail Andrews","KAA",14,TRUE,5,2,2,2,TRUE,TRUE,TRUE,1,"13",FALSE
